Dencare (Chongqing) Oral Care Co., Ltd. (SHE:001328)
China · Delayed Price · Currency is CNY 31.70
-0.13 (-0.41%)
At close: Jul 31, 2026
SHE:001328 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 5,458 | 6,797 | 5,468 | 4,874 | - | - | |
Market Cap Growth | -28.70% | 24.31% | 12.19% | - | - | - |
Enterprise Value | 4,340 | 5,631 | 4,106 | 3,660 | - | - |
Last Close Price | 31.70 | 38.34 | 30.42 | 26.44 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 28.82 | 37.54 | 33.93 | 34.50 | - | - |
Forward PE | 25.29 | 31.58 | 31.35 | 28.50 | - | - |
PS Ratio | 3.06 | 3.96 | 3.51 | 3.54 | - | - |
PB Ratio | 3.47 | 4.52 | 3.76 | 3.47 | - | - |
P/TBV Ratio | 3.51 | 4.58 | 3.81 | 3.51 | - | - |
P/FCF Ratio | 31.65 | 41.07 | 40.71 | 45.70 | - | - |
P/OCF Ratio | 26.85 | 31.70 | 30.20 | 32.33 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.44 | 3.28 | 2.63 | 2.66 | - | - |
EV/EBITDA Ratio | 22.45 | 29.97 | 25.33 | 31.22 | - | - |
EV/EBIT Ratio | 25.06 | 33.60 | 29.10 | 34.95 | - | - |
EV/FCF Ratio | 25.16 | 34.02 | 30.57 | 34.31 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Debt / EBITDA Ratio | - | - | - | - | - | 0.00 |
Debt / FCF Ratio | - | - | - | - | - | 0.00 |
Net Debt / Equity Ratio | -0.71 | -0.86 | -0.85 | -0.94 | -0.70 | -0.75 |
Net Debt / EBITDA Ratio | -5.78 | -6.85 | -7.61 | -11.32 | -3.21 | -2.97 |
Net Debt / FCF Ratio | -6.48 | -7.78 | -9.19 | -12.45 | -13.62 | -7.78 |
Asset Turnover | 0.86 | 0.86 | 0.81 | 0.95 | 1.33 | 1.18 |
Inventory Turnover | 4.08 | 4.15 | 3.90 | 4.00 | 4.34 | 4.39 |
Quick Ratio | 2.45 | 2.94 | 2.83 | 3.48 | 1.12 | 1.20 |
Current Ratio | 3.49 | 3.37 | 3.33 | 4.01 | 1.71 | 1.68 |
Return on Equity (ROE) | 12.35% | 12.24% | 11.27% | 14.51% | 25.62% | 23.39% |
Return on Assets (ROA) | 5.23% | 5.27% | 4.60% | 4.53% | 6.83% | 7.65% |
Return on Invested Capital (ROIC) | 44.82% | 66.61% | 81.83% | 77.09% | 69.87% | 107.07% |
Return on Capital Employed (ROCE) | 10.70% | 10.80% | 9.30% | 7.10% | 17.20% | 19.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.48% | 2.66% | 2.95% | 2.90% | - | - |
FCF Yield | 3.16% | 2.44% | 2.46% | 2.19% | - | - |
Dividend Yield | 2.68% | 2.22% | 2.46% | 2.46% | - | - |
Payout Ratio | 68.07% | 71.31% | 69.43% | 73.11% | 74.82% | 128.10% |
Buyback Yield / Dilution | -0.14% | -0.58% | -6.79% | -24.05% | -0.18% | -7.17% |
Total Shareholder Return | 2.54% | 1.64% | -4.33% | -21.59% | -0.18% | -7.17% |